Details for Patent: 10,512,620
✉ Email this page to a colleague
Which drugs does patent 10,512,620 protect, and when does it expire?
Patent 10,512,620 protects SOTALOL HYDROCHLORIDE and is included in one NDA.
Summary for Patent: 10,512,620
| Title: | Method of initiating and escalating sotalol hydrochloride dosing |
| Abstract: | This disclosure provides method of safely and efficaciously treating or preventing atrial fibrillation, atrial flutter, or a combination thereof via rapid intravenous introduction of sotalol hydrochloride to a subject in need thereof. |
| Inventor(s): | Somberg; John Charin (Chicago, IL), Kashfian; Brandon Ira (Chicago, IL), Molnar; Janos (Chicago, IL) |
| Assignee: | AltaThera Pharmaceuticals, LLC (Chicago, IL) |
| Application Number: | 16/103,815 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,512,620 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; Dosage form; |
Drugs Protected by US Patent 10,512,620
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altathera Pharms Llc | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | SOLUTION;INTRAVENOUS | 022306-001 | Jul 2, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | DOSING REGIMEN FOR INTRAVENOUS SOTALOL FOR ADMINISTRATION IN A FACILITY THAT CAN PROVIDE CONTINUOUS ELECTROCARDIOGRAPHIC MONITORING AND CARDIAC RESUSCITATION. | ⤷ Sign Up | ||||
| Altathera Pharms Llc | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | SOLUTION;INTRAVENOUS | 022306-001 | Jul 2, 2009 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | INTRAVENOUS SOTALOL DOSING REGIMEN FOR ACHIEVING STEADY STATE EXPOSURE IN A FACILITY THAT CAN PROVIDE ELECTROCARDIOGRAPHIC MONITORING | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
